Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,418 public trials 1,316 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.

NCT00670007

Conditions
Alpha 1-proteinase Inhibitor Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Study Site Adelaide, South Australia, Australia
  • Study Site Fitzroy, Victoria, Australia
  • Study Site Darlinghurst, Australia
  • Study Site Nedlands, Australia
View all 21 locations
View Trial Details
Completed

A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment

NCT02864199

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • Kansas City, Kansas, United States
  • New Orleans, Louisiana, United States
  • Kansas City, Missouri, United States
View all 17 locations
View Trial Details
Completed

Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue

NCT01480284

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Chiba, Japan
  • GSK Investigational Site Fukui, Japan
View all 32 locations
View Trial Details
Completed

PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

NCT01066819

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • Birmingham, Alabama, United States
  • Birmingham, Alabama, United States
  • Dothan, Alabama, United States
View all 106 locations
View Trial Details

Related conditions